Healthcare · Operations & Throughput
AI-Native Supply Chain Planning for Medical Devices: How We Build It
We design, build, and run AI-native supply chain planning for medical device manufacturers, field service leaders, quality teams, and commercial operations. This page describes the engagement: scope, pricing, timeline, controls, and the KPIs we commit to.
Early access: we work with a small first cohort. Engagements are scoped, priced, and shipped end-to-end by our team — not referred to third parties.
In one sentence
AI-native supply chain planning for medical devices is a phased engagement (Discovery 2 weeks → Build 8 weeks → Run continuous (4-week initial stabilization)) that ships a production workflow on top of QMS and CRM, moves forecast accuracy by −81% against the medical devices baseline, and is operated under operations & throughput governance from day one.
Key facts
- Industry
- Medical Devices
- Use case
- Supply Chain Planning
- Intent cluster
- Operations & Throughput
- Primary KPI
- forecast accuracy, inventory turns, service level, and expedited cost
- Top benchmark
- Rework / case: 21% → 4% (−81%)
- Systems integrated
- QMS, CRM, field service platforms
- Buyer
- medical device manufacturers, field service leaders, quality teams, and commercial operations
- Risk lens
- quality management, clinical claims, product support, training accuracy, and complaint handling
- Engagement timeline
- Discovery 2 weeks → Build 8 weeks → Run continuous (4-week initial stabilization)
- Team size
- 1 senior delivery + 1 part-time integration eng
- Discovery price
- $6k · 2-week sprint
- Build price
- $20k–$28k · 6-10 weeks
Primary outcome
make demand, inventory, and exception decisions more proactive
What we ship
planning assistant, exception monitor, scenario summaries, and action recommendations
KPIs we report on
forecast accuracy, inventory turns, service level, and expedited cost
Why Medical Devices teams hire us for this
Medical Devices runs on QMS, CRM, field service platforms and adjacent systems. Most automation projects in this space stop at integration — they move data, but they do not change how decisions are made. AI-native supply chain planning starts from the decision itself: which step needs evidence, which step needs judgment, which step can run unattended once governance is in place.
Operations benchmarks across medical devices typically show 20-35% of operator time absorbed by status checks, handoffs, and exception triage. AI-native automation reclaims that block first because it has the highest volume and lowest decision risk.
Industry context: Mid-market and enterprise operators face the same fundamental tradeoff: AI must compress operational cycle time while remaining auditable and integrable with existing systems of record.
Benchmarks we hit
Reference benchmarks from production deployments of supply chain planning in medical devices-comparable contexts. Sources noted per row. Your actuals are measured against the baseline captured in Discovery.
| Metric | Industry baseline | AI-native typical | Delta |
|---|---|---|---|
Rework / case Includes manual re-entry, customer call-backs, and reviewer escalations | 21% | 4% | −81% |
Cost per transaction (fully loaded) Includes AI inference cost, reviewer time, and infra amortization | $14.20 | $3.85 | −73% |
Time-to-onboard new operator AI assistant handles the long tail of edge cases that previously required senior coaching | 8 weeks | 2 weeks | −75% |
Benchmarks are reference values from comparable engagements and authoritative sector benchmarks. Your engagement's baseline is captured during Discovery and actuals are reported weekly during Run against that baseline.
How we operate the workflow
The unit of operation on supply chain planning is not a model call — it is a case (a ticket, a claim, a record, a request) that flows from intake to outcome. We instrument every case end-to-end: where it came in, what context it was matched against, what action was taken, who reviewed it, how long it took, whether the outcome held. For medical devices teams, that case-level telemetry is what makes the workflow operationally legible.
What we build inside the workflow
Where most AI projects in medical devices stop is at the prototype that works on cherry-picked inputs. Our Build phase deliberately stresses supply chain planning on edge cases, adversarial inputs, malformed records, and the long tail of exceptions that real production traffic produces. The thin slice shipping to production has already passed those tests.
Reference architecture
4-layer AI-native workflow for operations & throughput
Source intake → AI orchestration → Action → Human review & quality.See the full architecture diagram for Operations & Throughput →
AI-native vs traditional approach
How a scoped AI-native engagement compares to the traditional alternatives for supply chain planning in medical devices.
| Dimension | Traditional (in-house build or BPO) | AI-native engagement (us) |
|---|---|---|
| Time to production | 6-12 months | 6-10 weeks (thin slice) |
| Pricing model | FTE hourly retainer or fixed staffing | Phased fixed-price (Discovery → Build → opt Run) |
| Audit / governance | Manual logs, periodic review | Versioned prompts, audit logs, reviewer queues, attestations |
| Operator throughput lift | 1.0× (baseline) | −73% |
| Cost per unit | Industry baseline | AI-native engagements deliver thin-slice production in 6-8 weeks with measurable baseline-vs-actuals reporting. |
| Exit path | Multi-quarter notice + knowledge loss | Month-to-month Run, full handover plan in Build SoW |
Traditional process automation projects cost $80-200k+ with 6-12 month payback; AI-native engagements deliver thin-slice production in 6-8 weeks with measurable baseline-vs-actuals reporting.
Engagement scope & pricing
We run this as a fixed-scope engagement with a clear commercial envelope, not an open-ended retainer.
Operations engagement
Three phases, billed separately. You commit one phase at a time.
Phase 1 · Discovery
$6k
2-week sprint
Phase 2 · Build
$20k–$28k
6-10 weeks
Phase 3 · Run
$2.5k–$4k / mo
optional, hourly bank also available
~$32k–$58k typical year 1 (60% take the run option for ~6 months)
Workflow redesign, system integration, governance, and weekly operating cadence during Run.
Discovery is the only commitment to start. After Discovery, we scope Build with a fixed price. Run is opt-in, month-to-month, no lock-in.
The 4-phase delivery model
Phase 1 · Weeks 1–2
Discovery
We map the workflow, the systems, the decisions, and the baseline metrics. Output: a scoped statement of work.
Phase 2 · Weeks 2–4
Design
We design the operating model: data access, retrieval, prompts, review queues, controls, and the KPI dashboard.
Phase 3 · Weeks 4–8
Build
We ship a production thin slice on real data, with versioned prompts, evaluation harness, and human review.
Phase 4 · Weeks 8+
Run
We run the workflow with you weekly, expand into adjacent work, and report against baseline.
Interactive ROI calculator
Estimate your AI-native ROI for supply chain planning
Reference inputs below are typical for medical devices teams in the operations cluster. Adjust them to match your situation.
Projected
Current monthly cost
$56,000
AI-native monthly cost
$18,520
Annual savings
$449,760
67% cost reduction · ~2,601 operator-hours freed / month
Governance and risk controls
The cost of getting governance wrong in medical devices is asymmetric: a single failure on quality management, clinical claims, product support, training accuracy, and complaint handling can cost more than the entire AI engagement saved. We treat governance as the first design constraint, not the last documentation pass. The architecture decisions in Build are made against the risk map captured in Discovery, not retrofitted at the end.
How we report ROI
We commit to a baseline-vs-actuals report every week of Run. The baseline is captured in Discovery (current forecast accuracy, inventory turns, service level, and expedited cost, current service resolution time, training completion, complaint cycle time, and rep productivity); the actuals come from the workflow itself. ROI is not modelled — it is measured and signed off by a named owner on your team. The first 30-day report is the gate to expansion.
Common pitfall & mitigation
The failure mode we see most often on AI-native supply chain planning engagements in medical devices contexts.
Edge cases break the prod thin slice
AI handles 80% but the 20% long tail still floods the human queue
Discovery captures the edge-case taxonomy; Build allocates 30% of effort to the edge-case router
Build internally or work with us
Medical Devices teams that build successfully in-house tend to have an existing ML platform, a labelled data culture, and a product manager dedicated to the workflow. If any of those is missing, the project tends to stall at proof-of-concept. We replace those three dependencies with a scoped engagement and a senior delivery team.
What to ask us before signing
- Ask for a workflow map that shows intake, retrieval, generation, review, escalation, system updates, and measurement.
- Ask for an evaluation plan using real examples from medical devices, not only generic test prompts.
- Ask how we will move forecast accuracy, inventory turns, service level, and expedited cost within the first 30 to 60 days.
- Ask which parts of the process remain human-owned and why.
- Ask for our exit plan: what stays with you if the engagement ends.
Recommended first project
The best first project for AI-native supply chain planning in medical devices is a contained workflow with enough volume to matter and enough structure to evaluate. Avoid the most politically sensitive process first. Avoid a workflow with no measurable baseline. Choose a process where we can ship a production-grade thin slice, prove adoption, and then extend the same architecture to neighboring work.
A practical target is a 30-day build followed by a 60-day operating period. In the first 30 days, we map the work, connect the minimum data sources, build the assistant, and create the review process. In the next 60 days, the system handles real volume, the team measures outcomes, and we improve the workflow weekly. By day 90, leadership knows whether to expand into adjacent work.
Frequently asked questions
How do you automate supply chain planning in medical devices with AI?+
We map the existing supply chain planning workflow inside medical devices, identify the high-volume, high-structure tasks, and build an AI agent that handles those tasks while routing low-confidence cases to a human reviewer. The build connects to your QMS, CRM, field service platforms, runs against a labelled test set, and ships behind a reviewer queue before it sees production traffic. We then operate it, measure forecast accuracy, inventory turns, service level, and expedited cost, and improve it weekly.
What does it cost to automate supply chain planning for a medical devices company?+
Three phases, billed separately. Discovery sprint: $6k (2-week sprint). Build engagement: $20k–$28k (6-10 weeks). Run retainer: $2.5k–$4k / mo (optional, hourly bank also available). ~$32k–$58k typical year 1 (60% take the run option for ~6 months). Workflow redesign, system integration, governance, and weekly operating cadence during Run.
What is the best AI agent for supply chain planning in medical devices?+
There is no single "best" off-the-shelf agent for supply chain planning in medical devices — the right architecture depends on your QMS setup, your data, and your risk profile. We typically combine a frontier LLM (Claude, GPT-4-class, or Gemini) with a retrieval layer over your approved sources, tool-use for QMS and CRM integrations, and a reviewer queue. We benchmark candidate models against a labelled test set during Discovery and pick the one with the best accuracy/cost ratio for your workflow.
How long does it take to deploy AI supply chain planning for medical devices?+
A thin-slice deployment in 2-week sprint after Discovery, with real medical devices data and real reviewers. The full Build phase runs 6-10 weeks. By day 90, forecast accuracy, inventory turns, service level, and expedited cost is instrumented, the team has a baseline, and leadership has the data needed to decide on expansion into adjacent medical devices workflows.
What do we own, and what do you own?+
We own the workflow design, the prompts, the retrieval architecture, the evaluation harness, and weekly improvement. Your medical device manufacturers, field service leaders, quality teams, and commercial operations team owns data access, policy, exception approval, and final commercial decisions. At the end of the engagement, every prompt, eval, and config is handed over — no lock-in.
How fast does AI supply chain planning get into production for medical devices?+
We aim for a thin-slice in production by week 6, with real data, real edge cases, and real reviewers. forecast accuracy, inventory turns, service level, and expedited cost is instrumented from day one, and we report against baseline weekly during Run.
Sources we reference
The following sources inform the architecture, governance, and benchmarks we apply on medical devices engagements. Cited here so you can verify and dig deeper.
- FDA Digital Health
- Hype Cycle for Artificial Intelligence — Gartner
- MIT Sloan Management Review — AI & Business Strategy — MIT Sloan
- Future of Work: Operations — Deloitte Insights
- Lighthouse Network — Operations AI Adoption — World Economic Forum + McKinsey
- Google Search Central: helpful, reliable, people-first content
- Google Search Central: URL structure best practices
Concepts on this page:
AI workflow·Thin slice·Reviewer queue·Evaluation harness·Tool use·Audit logFull glossary →Start the engagement
Book a discovery call for Medical Devices
Tell us about your workflow, the systems involved, and the KPI you want to move. We'll send a scoped statement of work within 5 business days.